GBR-401 - CAS 1931954-95-8

GBR-401 is a humanized anti-CD19 monoclonal antibody with high affinity for FcγRIIIa. It exhibits potent cytotoxicity in vitro and in vivo against various B-cell malignancies. GBR-401 induces cell death through antibody-dependent cellular cytotoxicity (ADCC) and direct cytotoxic effects. In severe combined immunodeficiency (SCID) mouse models with various xenografts, GBR-401 effectively eliminates malignant B cells and prolongs survival.

Immunology/Inflammation related

Immunology/Inflammation

1931954-95-8

-20°C

Ice Packs

Inhibitory Antibodies